All In Biotech

Drug Trial Radar · NCT01141023

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression

The Parkinson's Progression Markers Initiative (PPMI)

Last checked: Nov 20, 2026Latest source record: Nov 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

952

Actual

Start

Jun 2010

Primary completion

Jun 30, 2020

Study completion Jun 30, 2020

Sponsor

Lead sponsor
Ken Marek, MDAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Institute for Neurodegenerative Disorders
First posted
Jun 10, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
Who can join
All sexes, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a observational, multi-center study to assess progression of clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients compared to healthy controls (HC) and in PD patient subtypes. The primary objective of this study is to identify clinical, imaging and biologic markers of PD progression for use in clinical trials of disease-modifying therapies.

Conditions

  • Parkinson Disease

Interventions

  • DaTscanDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Rates of ChangeTime frame: Baseline to 156 months

Locations

34 sites in 11 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Banner Research Institute

    Sun City, Arizona

  • University of California San Diego

    La Jolla, California

  • University of California, San Francisco

    San Francisco, California

  • The Parkinson's Institute

    Sunnyvale, California

  • Institute For Neurodegenerative Disorders

    New Haven, Connecticut

  • Parkinson's Disease& Movement Disorder Center of Boca Raton

    Boca Raton, Florida

  • University of South Florida

    Tampa, Florida

  • Emory University School of Medicine

    Atlanta, Georgia

  • Northwestern University

    Chicago, Illinois

  • John Hopkins University

    Baltimore, Maryland

  • Boston University

    Boston, Massachusetts

  • Beth Israel Medical Center

    New York, New York

  • Columbia University Medical Center

    New York, New York

  • University of Rochester

    Rochester, New York

  • University of Cincinnati/Cincinnati Children's Hospital

    Cincinnati, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • Oregon Health &Science University

    Portland, Oregon

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Baylor College of Medicine

    Houston, Texas

  • Univ of Washington and VA Puget Sound Health Care System

    Seattle, Washington

  • Macquarie University

    Sydney, Australia

  • Innsbruck Medical University

    Innsbruck, Austria

  • Hospital Pitie-Salpetriere

    Paris, France

  • Paracelsus-Elena Klinik

    Kassel, Germany

  • University of Tuebingen

    Tübingen, Germany

  • Foundation for Biomedical Research of the Academy of Athens

    Athens, Greece

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

  • Universita Federico II

    Naples, Italy

  • University of Salerno

    Salerno, Italy

  • St. Olavs Hospital

    Trondheim, Norway

  • Hospital Clinic de Barcelona

    Barcelona, Spain

  • Hospital Donostia

    Donostia / San Sebastian, Spain

  • Imperial College London

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.